Senior VP, Clinical Development

Lawrence Severt is our Senior Vice President of Clinical Development. He has extensive experience in clinical neurodegenerative diseases. Lawrence began his medical career in a large academic movement disorders practice in the Mount Sinai system in New York, where he treated patients with complex neurological diseases and served as principal investigator for numerous clinical trials. When he moved to industry, he joined the clinical development teams at Allergan/AbbVie to bring two oral CGRP-receptor antagonists from early phase to market (Ubrelvy and Qulipta). Lawrence holds an M.D./Ph.D. degree from the Medical College of Virginia, a Graduate Diploma in Neuroscience from the Australian National University, and a Bachelor’s degree in East Asian Studies from Princeton University. Outside of Leal, Lawrence enjoys getting his hands dirty in his vegetable garden and getting his feet dirty on adventures with his dog, Jack.